PPT-CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL

Author : sophie | Published Date : 2023-12-30

Y S un J Li J Ma C Wang F Bai K Zhao Z Yu W Kang Y Zhuang N Yao Q Liu B Dang B Wang Q Wei Z Liu L Wang W Kang L Wang J Xia T Wang T Zhu Tangdu Hospital

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LAT..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL: Transcript


Y S un J Li J Ma C Wang F Bai K Zhao Z Yu W Kang Y Zhuang N Yao Q Liu B Dang B Wang Q Wei Z Liu L Wang W Kang L Wang J Xia T Wang T Zhu Tangdu Hospital. Module 10:. Pharmacovigilance. Background – definitions. Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing use. Burden of adverse drug reactions in children. Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016). Sean Schafer MD. May 31, 2012. Three Studies in One. Evaluating antiretroviral drug resistance surveillance in Oregon. Determining frequency of transmitted antiretroviral drug resistance, comparing to U.S.. In the Classroom. January/February 2013 issue . of . Radiologic . Technology. Instructions:. This presentation provides a framework for educators and students to use Directed Reading content published in . Update. David Spach, MD. Professor of Medicine, Division of Infectious Diseases. University of Washington. Last Updated: . June 12. , 2013. Chronic Viral Diseases and Mortality in United States. Which one of the chronic viral diseases was responsible for the most number of deaths in the United States in 2007?. Drew Lambert, . PharmD. lambertd@husson.edu. Husson University School of Pharmacy. 1. I have no conflicts of interest.. However, I will be using brand names extensively during the presentation. Majority of the drugs used are brand-only. Jeffrey B. Joy, Richard H. Liang, Rosemary M. McCloskey, Thuy Nguyen, Chanson J. Brumme, Guillaume Colley, Robert S. Hogg, Julio S.G. Montaner, P. Richard Harrigan, and Art F.Y. Poon. Conflict of Interest. اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . . 2013. Short-Course Antiretroviral Therapy in Primary HIV Infection. G-103 Ckbeceopap (Pubkop( CO>E) (Last updated December 24, 2019, last reviewed December 24, 2019)Carcinogenicity Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infectio The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina. Future Directions: Investigational Approaches to Antiretroviral Therapy. Washington, DC: . August . 24, . 2016. . Future Directions: . 1 Ju ne 2019 The New Standard Provider FAQ Early diagnosis of HIV infection, followed by prompt antiretroviral therapy ( ART ) initiation , expands the concept of universal ART . There are cle (Last updated December 30, 2021; last reviewed December 30, 2021) Panel’s Recommendations When acute HIV infection is suspected in pregnancy or during breastfeeding, a plasma HIV RNA test should A5173 Study. Intensive . Enfuvirtide. -containing Antiretroviral Therapy . A5173: . Study Design. Source: Gandhi RT, et al. . J . Infect. . Dis. . . 2010;201(2. ):293-6.. Enfuvirtide. +. TDF + (FTC or 3TC) +. therapy. . on. . the. CD4/CD8 ratio and CD8 . cell. . counts. in . CoRIS. : . a . prospective. . multicentre. . cohort. . study. .. Serrano-Villar S, et al. . Lancet. HIV 2020; 7: e565-73. Juan E. Losa. OAA03 ‘Finding the needle in the haystack: Progress in understanding the HIV reservoir’. Michael Roche, PhD . Department of Infectious Diseases, . The University of Melbourne at the Peter Doherty Institute for Infections and Immunity, Australia.

Download Document

Here is the link to download the presentation.
"CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents